Hasil Pencarian - Dean Tsarwhas
- Menampilkan 1 - 1 hasil dari 1
-
1
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer oleh Ami N Shah, Lisa Flaum, Irene Helenowski, Cesar A Santa-Maria, Sarika Jain, Alfred Rademaker, Valerie Nelson, Dean Tsarwhas, Massimo Cristofanilli, William Gradishar
Diterbitkan 2020-06-01
Artikel